Source: Frontiers in Pharmacology. Unidades: EEFE, FM, ICB
Subjects: REPOSICIONAMENTO DE FÁRMACOS, NEOPLASIAS, BETA-BLOQUEADORES, ESTATINAS, SOBREVIVÊNCIA LIVRE DE DOENÇA
ABNT
BRAGA, Pedro Gabriel Senger et al. β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1423502. Acesso em: 16 maio 2025.APA
Braga, P. G. S., Vieira, J. da S., Gurgel, A. R. B., & Brum, P. C. (2024). β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1423502NLM
Braga PGS, Vieira J da S, Gurgel ARB, Brum PC. β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 maio 16 ] Available from: https://doi.org/10.3389/fphar.2024.1423502Vancouver
Braga PGS, Vieira J da S, Gurgel ARB, Brum PC. β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 maio 16 ] Available from: https://doi.org/10.3389/fphar.2024.1423502